Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (274)
- COVID-19 (163)
- Safety monitoring and information (99)
- Legislation (93)
- Compliance and enforcement (67)
- Vaping hub (53)
- Manufacturing (52)
- Labelling and packaging (35)
- Scheduling (national classification system) (27)
- Import and export (26)
- Medicinal cannabis hub (25)
- Sunscreens (16)
- Shortages and supply disruptions (14)
- Weight loss products (14)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1260 result(s) found, displaying 201 to 225
-
Regulatory decision noticesThis instrument is made under regulations 10AB, 10F and 10H of the Therapeutic Goods Regulations 1990.
-
News articlesSome changes are rolling out soon to improve your experience using guidance on our website. We’re aiming to make our content clearer, more accessible and easier to navigate.
-
News articlesSome medical device equipment could soon be affected as mobile network operators prepare to switch off their 3G networks.
-
Media releasesA two-day joint enforcement operation has led to the seizure of more than 10,000 nicotine pouches and hundreds of illicit vaping goods.
-
Regulatory decision noticesFind out about our position on Messenger RNA (mRNA) technology.
-
Safety updatesAn updated warning about the risk of sudden cardiovascular death has been added to the Product Information and Consumer Medicine Information documents for azithromycin.
-
Media releasesThe TGA reminds businesses and media outlets that it is unlawful to publicly advertise prescription-only medicines, including prescription-only weight loss medicines.
-
News articlesWe are advising sponsors of updates to the Generic Medicines Work-Sharing Initiative (GMWSI) operational procedures.
-
News articlesFollowing an extensive internal and external consultation process, we have adopted the following 13 international scientific guidelines.
-
News articlesThe TGA is updating acceptable intake information for nitrosamine impurities in medicines.
-
Regulatory decision noticesInformation for manufacturers and sponsors regarding a new method for GMP inspections that will be used from 1 July 2024 and the extended validity of TGA issued GMP Certificates.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
News articlesThe Scheme allows businesses to surrender certain quantities of vaping goods that were lawful prior to 1 July 2024. Notify us before September 2024 to participate.
-
Media releasesInfringement notices were issued to businesses and individuals for the alleged unlawful advertising of prescription-only medicines on their websites.
-
Media releasesTGA has issued 3 infringement notices totalling $56,340 to News Life Media Pty Ltd for alleged unlawful advertising of medicinal cannabis on their popular lifestyle website Body+Soul.
-
Regulatory decision noticesSix monthly report – supply of unapproved therapeutic goods by a sponsor.
-
Compliance undertakingsWe have accepted an enforceable undertaking from 2San Pty Ltd in relation to breaches of the Therapeutic Goods Act 1989. This relates to the company's unlawful import and supply of medical devices.
-
2San Pty Ltd enters into enforceable undertaking after unlawful import and supply of medical devices
Media releasesThe company imported medical devices not included in the Australian Register of Therapeutic Goods. They supplied these devices to a national retailer, who then sold them to the public. -
Media releasesThe Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024 will take effect on 1 July 2024, following passage through the Australian Parliament.
-
Media releasesTGA has issued 35 infringement notices totalling $627,252 to 6 businesses and 2 individuals for the alleged unlawful advertising of medicinal cannabis on their websites and social media platforms.
-
News articlesFind out about regulatory changes to a range of medical devices and application audit requirements.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
News articlesPrescription lenses supplied only for refractive correction are now exempt from inclusion in the Australia Register of Therapeutic Goods (ARTG) prior to import, export or supply in Australia.
-
Media releasesTGA has commenced proceedings in the Federal Court of Australia against Key Promotional Products Pty Ltd, and an individual, for allegedly importing and supplying unapproved rapid antigen test kits
-
Media releasesAmendments to the Therapeutic Goods Regulations 1990 (Schedule 5, item 6) have been made resulting in compounded GLP-1 RA products no longer being able to be compounded by pharmacists and supplied to patients.